Mechanism of Nuclear Defects in Hutchinson-Gilford Progeria Syndrome
Mechanism of Nuclear Defects in Hutchinson-Gilford Progeria Syndrome
批准号:
7472794
负责人:
Yue Zou
金额:
$5.82万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-03-01 至 2010-02-28
关键词:
AddressAgeAgingBindingBiologicalBiological ProcessCell AgingCellsComplexDNA AdductsDNA DamageDNA Double Strand BreakDNA damage checkpointDataDefectDevelopmentDiseaseDouble Strand Break RepairEmployee StrikesExcisionFeasibility StudiesFutureGenesGenomic InstabilityGoalsGrantHandHumanInvestigationLaboratoriesLamin Type ALeadLifeLinkLocalizedLongevityMolecularMutationNatureNuclearNuclear EnvelopeNucleotide Excision RepairPCNA genePathway interactionsPhenotypePlayPremature aging syndromeProgeriaProteinsPublic HealthQuality of lifeRNA InterferenceRiskRoleSiteSkeletonSmall Interfering RNAStudy modelsSyndromeTestingUV inducedXeroderma Pigmentosumbasecell agecytotoxicityinnovationnormal agingnovelnovel strategiesphotolesionprogramsrepairedresponsesenescence
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Cellular accumulation of DNA double strand breaks (DSBs) has been widely suggested to be a hallmark step leading to premature aging, cellular senescence, and aging. However, how DSB can accumulate in the cells that have intact DSB repair genes remains unknown. Our recent unexpected novel findings on the possible involvement of xeroderma pigmentosum group A (XPA) in the laminopathy-based premature aging, typically Hutchinson-Gilford progeria syndrome (HGPS), open an opportunity to address this challenging question. Interestingly, the same lamin A-related molecular mechanism responsible for HGPS was recently found to be active in human aging. Although XPA, a protein exclusively involved in nucleotide excision repair (NER), has no role in DSB repair, our preliminary data showed that XPA dysfunctionally localizes to DSB sites in laminopathy-based premature aging cells, implying the possible blockage of the recruitment of DSB repair proteins to the damage sites for repair. Strikingly, siRNA knockdown of XPA in the progeroid cells partially restored DSB repair. The goal of this project is to delineate the molecular basis of DSB accumulation and the role of XPA in laminopathy-related premature aging, particularly HGPS, and aging, and to gain a potential major advance in understanding the basic mechanisms of premature aging and aging. We will test the main hypothesis that XPA plays an important role in development of accelerated aging. The investigation will be carried out in five Specific Aims: (1) To elucidate the molecular basis of XPA-DSB mislocalization in progeria cells; and (2) To determine the effects of XPA-DSB mislocalization on cellular DNA damage responses. Due to its novelty and potential impact, this project may involve considerable risk but represents a highly innovative effort with the potential to lead to a breakthrough in understanding the mechanism of premature aging and aging, which fits well into the theme of pilot or feasibility studies of the Small Grant Program. Public Health Relevance: Aging which is a normal, but puzzling biological process, not only governs human lifespan, but also significantly reduces the quality of life due to the development of gerontological diseases. On the other hand, abnormal aging such as premature aging is a typical phenotype of devastating progeria diseases. While it is believed that one of the major causes to premature aging and aging is the accumulation of DNA damage in cells, the underlying molecular mechanism remains elusive. This project represents an initial or pilot effort with a long-term goal aiming to delineate the mechanisms of human premature aging and aging, and to provide a molecular basis for future development of novel strategies for better treatment of progeria and gerontological diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ATR Isomerization in Cellular Responses to UV Damage of DNA
-
批准号:9361724
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2017
-
负责人:Yue Zou
-
依托单位:
ATR Isomerization in Cellular Responses to UV Damage of DNA
-
批准号:10459421
-
项目类别:
-
资助金额:$39.27万
-
财政年份:2017
-
负责人:Yue Zou
-
依托单位:
ATR Isomerization in Cellular Responses to UV Damage of DNA
-
批准号:10012775
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Yue Zou
-
依托单位:
ATR Isomerization in Cellular Responses to UV Damage of DNA
-
批准号:10220898
-
项目类别:
-
资助金额:$35.34万
-
财政年份:2017
-
负责人:Yue Zou
-
依托单位:
Antiapoptotic Role of Ataxia Telangiectasia and Rad3-Related
-
批准号:9263097
-
项目类别:
-
资助金额:$10.66万
-
财政年份:2014
-
负责人:Yue Zou
-
依托单位:
Antiapoptotic Role of Ataxia Telangiectasia and Rad3-Related
-
批准号:8770880
-
项目类别:
-
资助金额:$31.58万
-
财政年份:2014
-
负责人:Yue Zou
-
依托单位:
Biochemical Insight of Hyperphosphorylation of Replication Protein A
-
批准号:8005163
-
项目类别:
-
资助金额:$7.4万
-
财政年份:2010
-
负责人:Yue Zou
-
依托单位:
Biochemical Insight of Hyperphosphorylation of Replication Protein A
-
批准号:7365510
-
项目类别:
-
资助金额:$20.89万
-
财政年份:2008
-
负责人:Yue Zou
-
依托单位:
Mechanism of Nuclear Defects in Hutchinson-Gilford Progeria Syndrome
-
批准号:7576814
-
项目类别:
-
资助金额:$5.85万
-
财政年份:2008
-
负责人:Yue Zou
-
依托单位:
RECOGNITION AND REPAIR OF UV DAMAGE TO HUMAN DNA
-
批准号:6514610
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2000
-
负责人:Yue Zou
-
依托单位:
RECOGNITION AND REPAIR OF UV DAMAGE TO HUMAN DNA
-
批准号:6377972
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2000
-
负责人:Yue Zou
-
依托单位:
Checkpoint Signaling and Repair of UV Damage to Human DNA
-
批准号:7476039
-
项目类别:
-
资助金额:$23.14万
-
财政年份:2000
-
负责人:Yue Zou
-
依托单位:
Checkpoint Signaling and Repair of UV Damage to Human DNA
-
批准号:7384182
-
项目类别:
-
资助金额:$24.44万
-
财政年份:2000
-
负责人:Yue Zou
-
依托单位:
Checkpoint Signaling and Repair of UV Damage to Human DNA
-
批准号:7930593
-
项目类别:
-
资助金额:$23.49万
-
财政年份:2000
-
负责人:Yue Zou
-
依托单位:
RECOGNITION AND REPAIR OF UV DAMAGE TO HUMAN DNA
-
批准号:6633762
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2000
-
负责人:Yue Zou
-
依托单位:
Checkpoint Signaling and Repair of UV Damage to Human DNA
-
批准号:7690289
-
项目类别:
-
资助金额:$20.87万
-
财政年份:2000
-
负责人:Yue Zou
-
依托单位:
RECOGNITION AND REPAIR OF UV DAMAGE TO HUMAN DNA
-
批准号:6159983
-
项目类别:
-
资助金额:$26.82万
-
财政年份:2000
-
负责人:Yue Zou
-
依托单位:
RECOGNITION AND REPAIR OF UV DAMAGE TO HUMAN DNA
-
批准号:6769910
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2000
-
负责人:Yue Zou
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: